Report cover image

Biomarkers Market Size, Share, and Analysis, By Type (Safety, Efficacy, and Validation), By Application (Diagnostics Development, Drug Discovery & Development, Personalized Medicine, Disease-Risk Assessment, and Others), By Product Type (Consumables, Serv

Publisher Fatpos Global
Published Feb 01, 2025
Length 573 Pages
SKU # FAGL19863370

Description

Biomarkers Market Size, Share, and Analysis, By Type (Safety, Efficacy, and Validation), By Application (Diagnostics Development, Drug Discovery & Development, Personalized Medicine, Disease-Risk Assessment, and Others), By Product Type (Consumables, Services, and Software), By Technology (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Biomarkers Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 13.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 64.3 billion and is projected to reach USD 249.6 billion by the completion of 2034.

Biomarkers are measurable indicators of biological states or conditions within an organism and serve as valuable tools in medical fields. These indicators can be genes, characteristics, or procedures that signify normal or abnormal function or the progression of a disease. Biomarkers offer important data about a person's health and are used in disease diagnosis, risk evaluation, and personalized medication. They can be found using imaging methods and in a variety of biological samples, such as blood, urine, and tissue. Thus, biomarkers are important for the development of healthcare and the improvement of patient outcomes as they allow for earlier identification and more precise diagnoses.

MARKET HIGHLIGHTS

Biomarkers Market is projected to reach USD 249.6 billion over the forecast period, owing to growing demand for personalized medicine and a high incidence of chronic diseases. The growth of the biomarkers market is further driven by high funding in pharmaceutical and biotech research, as well as an increase in healthcare spending. Additionally, the market is expanding due to the discovery of new biomarkers in the genomics, proteomics, and metabolomics segments. These biomarkers are classified based on various criteria like safety, efficacy, and predictive biomarkers. They are used in various medical domains such as brain disorders, cancer, and heart disease. However, despite the growth potential, challenges like high development costs and strict laws and regulations exist. Thus, the biomarkers market is predicted to expand due to its use in drug development and clinical diagnostics, which highlights its importance in offering healthcare solutions.

Biomarkers Market Segments:
  • By Type
  • Safety
  • Efficacy
  • Validation
  • By Application
  • Diagnostics Development
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease-Risk Assessment
  • Others
  • By Product Type
  • Consumables
  • Services
  • Software
  • By Technology
  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers
  • By Indication
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Immunological Disorders
  • Others
MARKET DYNAMICS

Growth Drivers

Rising Prevalence of Chronic Diseases is Driving Growth in the Biomarkers Market

Advancements in Technology Act as a Catalyst for Market Growth

Restraint

High Costs of Development in the Market Will Impact the Growth

Key Players
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Bruker Corporation
  • BD (Becton, Dickinson, and Company)
  • Hologic, Inc.
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 2-3 business days upon order confirmation*

Table of Contents

573 Pages
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Biomarkers Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Biomarkers Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Biomarkers Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Biomarkers Market
10.1. Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Biomarkers Market Size & Forecast 2024 A-2034 F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Safety
11.3.1.1.1. By Value (USD Million) 2024-2034 F
11.3.1.1.2. Market Share (%) 2024-2034 F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.1.2. Efficacy
11.3.1.2.1. By Value (USD Million) 2024-2034 F
11.3.1.2.2. Market Share (%) 2024-2034 F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.1.3. Validation
11.3.1.3.1. By Value (USD Million) 2024-2034 F
11.3.1.3.2. Market Share (%) 2024-2034 F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2. By Application
11.3.2.1. Diagnostics Development
11.3.2.1.1. By Value (USD Million) 2024-2034 F
11.3.2.1.2. Market Share (%) 2024-2034 F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.2. Drug Discovery and Development
11.3.2.2.1. By Value (USD Million) 2024-2034 F
11.3.2.2.2. Market Share (%) 2024-2034 F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.3. Personalized Medicine
11.3.2.3.1. By Value (USD Million) 2024-2034 F
11.3.2.3.2. Market Share (%) 2024-2034 F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.4. Disease Risk Assessment
11.3.2.4.1. By Value (USD Million) 2024-2034 F
11.3.2.4.2. Market Share (%) 2024-2034 F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024-2034 F
11.3.2.5.2. Market Share (%) 2024-2034 F
11.3.2.5.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3. By Product Type
11.3.3.1. Consumables
11.3.3.1.1. By Value (USD Million) 2024-2034 F
11.3.3.1.2. Market Share (%) 2024-2034 F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3.2. Services
11.3.3.2.1. By Value (USD Million) 2024-2034 F
11.3.3.2.2. Market Share (%) 2024-2034 F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3.3. Software
11.3.3.3.1. By Value (USD Million) 2024-2034 F
11.3.3.3.2. Market Share (%) 2024-2034 F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4. By Technology
11.3.4.1. Safety Biomarkers
11.3.4.1.1. By Value (USD Million) 2024-2034 F
11.3.4.1.2. Market Share (%) 2024-2034 F
11.3.4.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4.2. Efficacy Biomarkers
11.3.4.2.1. By Value (USD Million) 2024-2034 F
11.3.4.2.2. Market Share (%) 2024-2034 F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4.3. Validation Biomarkers
11.3.4.3.1. By Value (USD Million) 2024-2034 F
11.3.4.3.2. Market Share (%) 2024-2034 F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.5. By Indication
11.3.5.1. Cancer
11.3.5.1.1. By Value (USD Million) 2024-2034 F
11.3.5.1.2. Market Share (%) 2024-2034 F
11.3.5.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.5.2. Cardiovascular Disorders
11.3.5.2.1. By Value (USD Million) 2024-2034 F
11.3.5.2.2. Market Share (%) 2024-2034 F
11.3.5.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.5.3. Neurological Disorders
11.3.5.3.1. By Value (USD Million) 2024-2034 F
11.3.5.3.2. Market Share (%) 2024-2034 F
11.3.5.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.5.4. Immunological Disorders
11.3.5.4.1. By Value (USD Million) 2024-2034 F
11.3.5.4.2. Market Share (%) 2024-2034 F
11.3.5.4.3. Y-o-Y Growth (%) 2024-2034 F
11.3.5.5. Others
11.3.5.5.1. By Value (USD Million) 2024-2034 F
11.3.5.5.2. Market Share (%) 2024-2034 F
11.3.5.5.3. Y-o-Y Growth (%) 2024-2034 F
12. North America Biomarkers Market Size & Forecast 2024 A-2034 F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Application
12.3.3. By Product Type
12.3.4. By Technology
12.3.5. By Indication
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Biomarkers Market Size & Forecast 2024 A-2034 F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Application
13.3.3. By Product Type
13.3.4. By Technology
13.3.5. By Indication
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Biomarkers Market Size & Forecast 2024 A-2034 F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Application
14.3.3. By Product Type
14.3.4. By Technology
14.3.5. By Indication
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Biomarkers Market Size & Forecast 2024 A-2034 F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Application
15.3.3. By Product Type
15.3.4. By Technology
15.3.5. By Indication
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Biomarkers Market Size & Forecast 2024 A-2034 F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Application
16.3.3. By Product Type
16.3.4. By Technology
16.3.5. By Indication
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Thermo Fisher Scientific Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Roche Diagnostics
18.3. Abbott Laboratories
18.4. Siemens Healthineers
18.5. Danaher Corporation
18.6. Bio-Rad Laboratories, Inc.
18.7. GE Healthcare
18.8. Agilent Technologies, Inc.
18.9. Illumina, Inc.
18.10. Qiagen N.V.
18.11. Merck KGaA
18.12. PerkinElmer, Inc.
18.13. Bruker Corporation
18.14. BD (Becton, Dickinson and Company)
18.15. Hologic, Inc.
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us